| Old Articles: <Older 20591-20600 Newer> |
 |
The Motley Fool February 9, 2007 Selena Maranjian |
Growth, Value -- What's the Difference? What, exactly, is a growth stock? Fully 162 of the S&P 500's component stocks -- or 32% of the group -- are classified as both growth and value. This data may be interesting, but it tells us little about the attractiveness of specific stocks.  |
The Motley Fool February 9, 2007 Rick Aristotle Munarriz |
Float Like a Shutterfly The digital photography site soars during the holidays. Investors, this is a seasonal business. The next few quarters will be sleepy.  |
The Motley Fool February 9, 2007 Tom Taulli |
The Fortress IPO: Opening the Drawbridge to Hedge Funds With Fortress's IPO, retail investors can now get a shot at playing hedge funds and private equity. But at its current valuation, the risks are certainly hefty.  |
BusinessWeek February 19, 2007 Christopher Farrell |
Stocks: It's All In The Timing Sure, you could score big by riding the market's trends - but even the pros fail to do it regularly.  |
BusinessWeek February 19, 2007 Gene G. Marcial |
Hartford Is Leaping Up Shares of insurers are hardly on fire, but Hartford Financial Services stock is lit.  |
BusinessWeek February 19, 2007 Gene G. Marcial |
Will Healthy Lab Data Revive Ailing Cell Genesys? Cell genesys is in the midst of clinical trials of vaccines for prostate and pancreatic cancer that analysts believe should catch investors' eyes.  |
BusinessWeek February 19, 2007 Gene G. Marcial |
Why China's CDC May Climb Higher One top performer on the NASDAQ is CDC, whose stock has rocketed.  |
The Motley Fool February 8, 2007 Will Frankenhoff |
America Movil Keeps Going and Going ... Simply put, telecom investors with a taste for growth and an ability to tolerate a certain amount of volatility might want to call up this Latin American company's financials and take another look.  |
The Motley Fool February 8, 2007 Ryan Fuhrmann |
The Skinny on Whirlpool Short-term worries are hitting Whirlpool, but it has long-term appeal for investors.  |
The Motley Fool February 8, 2007 Buddy Howard |
Matrixx Passes the Sniff Test This over-the-counter health care provider is expected to post a loss for the fourth quarter, but that's pretty much reflected in the stock, so savvy investors should buy before then.  |
| <Older 20591-20600 Newer> Return to current articles. |